Arca Biopharma | ABIO - Current Liabilities


Arca Biopharma reported $22.97M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 25.5B 547M Jun/2026
Arca Biopharma USD 22.97M 6.34M Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 181.43M 17.76M Jun/2026
Daiichi Sankyo JPY 765.7B 119.32B Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Grifols EUR 2.37B 156.97M Dec/2025
Laboratory Of America USD 2.12B 516.4M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Otsuka Holdings JPY 738.96B 52.85B Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
United Therapeutics USD 607.8M 8.7M Jun/2026